DK0999849T3 - Anvendelse af LBP til sepsisbehandling - Google Patents

Anvendelse af LBP til sepsisbehandling

Info

Publication number
DK0999849T3
DK0999849T3 DK98928139T DK98928139T DK0999849T3 DK 0999849 T3 DK0999849 T3 DK 0999849T3 DK 98928139 T DK98928139 T DK 98928139T DK 98928139 T DK98928139 T DK 98928139T DK 0999849 T3 DK0999849 T3 DK 0999849T3
Authority
DK
Denmark
Prior art keywords
lbp
therapeutic agent
sepsis treatment
treatment
septicemia
Prior art date
Application number
DK98928139T
Other languages
Danish (da)
English (en)
Inventor
Ralf Reiner Schumann
Norbert Lamping
Original Assignee
Max Delbrueck Centrum
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Max Delbrueck Centrum filed Critical Max Delbrueck Centrum
Application granted granted Critical
Publication of DK0999849T3 publication Critical patent/DK0999849T3/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/1703—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • A61K38/1709—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/1703—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • A61K38/1709—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • A61K38/1751—Bactericidal/permeability-increasing protein [BPI]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Zoology (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Epidemiology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Marine Sciences & Fisheries (AREA)
  • Organic Chemistry (AREA)
  • Molecular Biology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Treatments For Attaching Organic Compounds To Fibrous Goods (AREA)
  • Saccharide Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Food Preservation Except Freezing, Refrigeration, And Drying (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
DK98928139T 1997-07-11 1998-04-04 Anvendelse af LBP til sepsisbehandling DK0999849T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE19729810A DE19729810C2 (de) 1997-07-11 1997-07-11 Mittel zur Sepsistherapie, seine Herstellung und seine Verwendung
PCT/DE1998/000964 WO1999002178A1 (de) 1997-07-11 1998-04-04 Mittel zur sepsistherapie, seine herstellung und seine verwendung

Publications (1)

Publication Number Publication Date
DK0999849T3 true DK0999849T3 (da) 2003-01-06

Family

ID=7835437

Family Applications (1)

Application Number Title Priority Date Filing Date
DK98928139T DK0999849T3 (da) 1997-07-11 1998-04-04 Anvendelse af LBP til sepsisbehandling

Country Status (9)

Country Link
US (1) US6949512B1 (enExample)
EP (1) EP0999849B1 (enExample)
JP (1) JP2001509488A (enExample)
AT (1) ATE223227T1 (enExample)
DE (2) DE19729810C2 (enExample)
DK (1) DK0999849T3 (enExample)
ES (1) ES2183376T3 (enExample)
PT (1) PT999849E (enExample)
WO (1) WO1999002178A1 (enExample)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2108372A1 (en) * 2008-04-09 2009-10-14 Forschungszentrum Borstel Leibniz-Zentrum für Medizin und Biowissenschaften Novel antimicrobial peptides

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1994025476A1 (en) * 1993-04-30 1994-11-10 Incyte Pharmaceuticals, Inc. Recombinant bpi-based and lbp-based proteins, nucleic acid molecules encoding same, methods of producing same, and uses thereof
EP0664814A1 (en) * 1993-08-18 1995-08-02 MorphoSys AG Lipopolysaccharide-binding and neutralizing peptides
WO1995008560A1 (en) * 1993-09-24 1995-03-30 Centocor, Inc. Novel peptides useful for inhibiting binding of lipopolysaccharides (lps) by lipopolysaccharide binding protein (lbp)
US5837810A (en) * 1994-03-15 1998-11-17 The Scripps Research Institute Polypeptides of lipopolysaccharide binding protein
US5990082A (en) * 1997-10-22 1999-11-23 Xoma Corporation Uses of lipopolysaccharide binding protein

Also Published As

Publication number Publication date
DE59805440D1 (de) 2002-10-10
WO1999002178A1 (de) 1999-01-21
JP2001509488A (ja) 2001-07-24
US6949512B1 (en) 2005-09-27
DE19729810A1 (de) 1999-01-14
DE19729810C2 (de) 2000-01-13
EP0999849B1 (de) 2002-09-04
PT999849E (pt) 2003-01-31
EP0999849A1 (de) 2000-05-17
ATE223227T1 (de) 2002-09-15
ES2183376T3 (es) 2003-03-16

Similar Documents

Publication Publication Date Title
FI954978L (fi) Modifioidut proteiini- ja peptidilääkeaineet
BR9607317A (pt) Peptídios e composição farmacêutica
BR9607318A (pt) Peptidos e composição farmacêutica
FI952119L (fi) Stabiili pakastekuivattu koostumus, joka sisältää proteiinia ja testipakkaus
DE69900746D1 (de) Gesteuerte verabreichung von peptiden oder proteinen
CY2007001I1 (el) Φαρμακευτικο σκευασμα για χρηση στη θεραπεια του διαβητη
DK0914144T3 (da) Terapeutiske anvendelser af BPI-protein-produkter til human meningokokæmi
NO965294D0 (no) Emulsjon, kosmetisk og farmasöytisk preparat inneholdende denne samt anvendelse derav
NO980915D0 (no) Rekombinante anti-CD4-antistoff egnet for human terapi
DE69434384D1 (de) Metalkomplexbildner
FI963781A7 (fi) Eristettyjä, MAGE-3-peräisiä peptidejä, jotka kompleksoivat HLA-A2-mol ekyylejä, ja niiden käyttöjä
BR9509172A (pt) Proteina de via de complemento nativa sequéncia de dna construção de dna conjugado uso de uma proteína processo para reduzir proteina de via de complemento em um mamifero e formulação farmacéutica
NO965102L (no) Bicykliske aromatiske forbindelser, anvendelser derav, og farmasöytiske og kosmetiske preparater
DE69714451D1 (de) Prionbindende proteine und deren verwendungen
DE69634489D1 (de) Adenovirus dodekahedrischer proteinkomplex, dieser enthaltende zusammensetzung und verwendungen davon
NZ500216A (en) Beta-amyloid peptide-binding proteins and pharmaceutical use
ID21034A (id) Protein kinase dan penggunaannya
DE69831084D1 (de) Beta-defensine
FI952738L (fi) Stabiiliproteiini, fosfolipidikoostumuksia ja menetelmiä
DK0999849T3 (da) Anvendelse af LBP til sepsisbehandling
PT723552E (pt) Oligopeptidos derivados de fragmentos de proteina reactiva c
FI956353L (fi) Farmaseuttiset valmisteet ja niiden käyttö etenkin neurodegeneratiivisten sairauksien hoidossa
NO980375D0 (no) Humant MP52 Arg protein
FI972965A7 (fi) Uusia peptidejä, niiden valmistus ja käyttö
WO2001051512A3 (en) Human and parasite orphan receptor proteins